Bright Peak Therapeutics
Better Biologics Through Chemistry
56 employees · est. 2017 · Basel, Switzerland
Synaffix is the older company (2017 vs 2014).
Side-by-Side Comparison
| Metric | Bright Peak Therapeutics | Synaffix |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2014 older |
| Headquarters | ||
| Headquarters | Basel, Switzerland | Oss, The Netherlands |
| Employees | ||
| Employees | 56 | 63 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series C | Acquired |
| Total Funding | ||
| Total Funding | $232.00M | $100.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Development of multifunctional precision immunotherapies through protein engineering and chemical synthesis | ADC Platform Licensing, Bispecific Antibody Development, Targeted Therapy Development, Out-licensing Technology for Cancer Therapeutics |
| Target Customers | ||
| Target Customers | Patients with cancer and autoimmune diseases, pharmaceutical companies, research institutions | Pharmaceutical Companies, Biotechnology Firms, Oncology Researchers, Strategic Partners in Therapeutics |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Biologics, Cytokines, Antibody Conjugation, Cancer Treatment, Autoimmune Disease Treatment, Therapeutic Antibodies, Drug Development, Innovation, Biotech Research, Cell-Specific Targeting, Efficacy Enhancement, Precision Medicine, ADC-like Conjugation Technology | Antibody-Drug Conjugates, ADC Technology Platform, Licensed Partnerships, Biotech Innovation, Clinical-Stage Development, Enzymatic Glycan Modification, Metal-Free Click Chemistry, Site-Specific Conjugation, Cancer Therapeutics, Immune Cell Engagers, Targeted Gene Therapy, Bispecific Antibodies, Patent Portfolio, Phase 1 Clinical Trials, High Growth Market Segments |
| Website | ||
| Website | brightpeaktx.com | synaffix.com |
About Bright Peak Therapeutics
Bright Peak Therapeutics, founded in 2017 and headquartered in Switzerland, is revolutionizing biologics with its pioneering approach. The company's portfolio of first-in-class and best-in-class cytokines, aimed at treating cancer and autoimmune diseases, leverages proprietary technology platforms t...
About Synaffix
Synaffix, a Lonza Company, is a pioneering biotech firm founded in 2014 and headquartered in The Netherlands. It boasts a proprietary, clinical-stage technology platform focused on antibody-drug conjugates (ADCs), renowned for optimizing safety and efficacy. The platform's value is underscored by m...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Bright Peak Therapeutics and Synaffix — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Bright Peak Therapeuti... and Synaffix — by email.
Frequently Asked Questions
Compare Bright Peak Therapeutics with someone else
Start typing a company name or domain.